Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

TSXV:MIR - Post Discussion

MedMira Inc > MIR poised for massive revenue growth in 2021
View:
Post by Jennifer2020 on Dec 28, 2020 12:02am

MIR poised for massive revenue growth in 2021

An FDA EUA for RealCovid 19 and an announcement of another $723,000 in income developing an ANTIGEN/Influenza 1 & 2 combo test will see huge orders sure to follow.

MIR will be looking at 10's of millions of revenue instead of 100's of thousands from the past.  

This is an example of the revenue potential out there from governments, airport authouritys and business interests:

As a readerless antigen test, the QuickVue test may be most similar to the BinaxNow from Abbott Laboratories. To date, the federal government has supported the Abbott test with $760 million in funding and distributed 80 million tests.
Comment by Rossaporino on Dec 28, 2020 1:13am
I agree  with you in this one. The future of antibody testing. Multi million dollars  market. And this is the beginning ...$$$$$$$$$$$$$$$
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities